--- title: Webinars --- [![Nanome_Logo_Horizontal-Black (1)](https://meet.nanome.ai/hs-fs/hubfs/Nanome_Logo_Horizontal-Black%20(1).png?width=185&height=30&name=Nanome_Logo_Horizontal-Black%20(1).png "Nanome_Logo_Horizontal-Black (1)")](https://nanome.ai/) Open main menu Close main menu - [Pricing](https://nanome.ai/pricing) - [Blog](https://blog.matryx.ai/) - [Press](https://nanome.ai/press) - [Resources](https://meet.nanome.ai/case-studies) Open the submenu - [Citations / Publications](https://nanome.ai/publications/) - [Blog](https://nanome.ai/blog/) - [Case Studies](https://meet.nanome.ai/case-studies) - [Events](https://meet.nanome.ai/events) - [Webinars](https://meet.nanome.ai/webinars) - [Docs](https://docs.nanome.ai/) - [Demo](https://nanome.ai/demo) - [Download](https://home.nanome.ai/setup) # Nanome Webinar Series # Stay tuned for future webinar announcements! ## Past Webinars ![Quillon Simpson PhD Chemistry](https://meet.nanome.ai/hubfs/Quillon%20Simpson%20PhD-1-1.jpeg) ### Quillon Simpson, PhD Scientific Business Development at Nanome ## Data Democratization with MARA by Nanome: How to Turn Bench Scientists into Data Scientists Recorded August 22nd, 2024 Hands-on demo of the MARA ecosystem How MARA makes drug discovery  easier and more efficient How you can access MARA Potential applications of MARA to your research organization ### View on Demand --- ![sam4_small copy](https://meet.nanome.ai/hubfs/sam4_small%20copy.jpg) ### Sam Hessenauer CTO & Co-Founder at Nanome ![mike bishop](https://meet.nanome.ai/hubfs/mike%20bishop.jpg) ### Michael Bishop, PhD Drug Discovery Consultant at Nanome ![chido](https://meet.nanome.ai/hubfs/chido.png) ### Chido Mpamhanga, PhD Applied Computational Chemistry Domain Expert at Nanome ## Amplifying the Human Element for AI in Drug Discovery: Introducing MARA by Nanome Recorded November 15th, 2023 Using LLM technologies to amplify informatics and data-driven decision making within drug discovery. Introduction of MARA, our new AI product purpose-built to be enterprise-ready, human centric, and collaborative ### View on Demand --- ![Jonathon Gast_sq (1)](https://meet.nanome.ai/hubfs/Jonathon%20Gast_sq%20(1).jpg) ### Jonathon Gast, PhD Senior Application Scientist at Nanome ![Steve-079-edited](https://meet.nanome.ai/hubfs/Steve-079-edited.jpg) ### Steve McCloskey CEO at Nanome ## PROTACs in Mixed Reality: exploring protein interfaces and poses using the Data Table Plugin Recorded June 29th, 2023 We showcase the Data Table plugin and demonstrate how to effectively use it when iterating on docking poses and exploring protein interfaces. Learn how to use the Data Table plugin, designed for scientists working with multi-frame data and set to help the decision-making progress every time you are dealing with structures and data in Nanome.  ### View on Demand --- ![Jonathon Gast_sq (1)](https://meet.nanome.ai/hubfs/Jonathon%20Gast_sq%20(1).jpg) ### Jonathon Gast, PhD Senior Application Scientist at Nanome ![Steve-079-edited](https://meet.nanome.ai/hubfs/Steve-079-edited.jpg) ### Steve McCloskey CEO at Nanome ## Revealing the new Nanome CryoEM plugin to target Prion Aggregates with Antibodies in XR Recorded May 11th, 2023 We show how to smoothly navigate CryoEM maps in VR/MR, and provide insights on how this cutting-edge technology can help researchers better target prion aggregates with antibodies. Learn how to visualize CryoEM maps in Nanome and how to leverage this plugin for your structural analysis.  ### View on Demand --- ![daniel gruffat](https://meet.nanome.ai/hubfs/daniel%20gruffat.jpg) ### Daniel Gruffat, MS Senior Application Scientist at Nanome ![Steve-079-edited](https://meet.nanome.ai/hubfs/Steve-079-edited.jpg) ### Steve McCloskey CEO at Nanome ## Revolutionizing Cancer Treatment: A Live Stream on the Latest Approved Inhibitor for Gastric Cancer Kinase Structures in Mixed Reality Recorded March 24th, 2023 Deep dive into the crystal structure of Tyrosine Kinase KIT1 in complex with DP2976, a close chloro analog of ripretinib, the latest approved inhibitor for gastrointestinal cancer.  We provide a live examples of how multisite collaboration in Nanome and Mixed Reality looks like.  ### View on Demand --- ![roberta barlotta](https://meet.nanome.ai/hubfs/roberta%20barlotta.jpeg) ### Roberta Bartolotta, PhD Application Scientist at Nanome ![Steve-079-edited](https://meet.nanome.ai/hubfs/Steve-079-edited.jpg) ### Steve McCloskey CEO at Nanome ## Exploring the Crystal Structure of CRBN (Human Cereblon) Protein in Complex with Small Molecules for Drug Discovery Research:  a Live Stream in Nanome and Quest Pro’s Mixed Reality Recorded February 24th, 2023 We analyzed the crystal structure of human Cereblon in complex with DDB1 and lenalidomide (PDBid 4tz4) LIVE! We’ll be showcasing Meta’s newest headset, the Meta Quest Pro, and viewers will be able to experience the Passthrough Mixed Reality capabilities along with Nanome’s powerful scientific use cases. ### View on Demand --- ![Jonathon Gast_sq (1)](https://meet.nanome.ai/hubfs/Jonathon%20Gast_sq%20(1).jpg) ### Jonathon Gast, PhD Senior Application Scientist at Nanome ![mike bishop](https://meet.nanome.ai/hubfs/mike%20bishop.jpg) ### Mike Bishop, PhD Drug Discovery Consultant at Nanome ## Collaborative Drug Design in XR Recorded December 13th, 2022 How drug design and discovery can be improved across teams using XR.  From pocket characterization to docking, and more, teams from all over the world can still come together in space through the power of XR tools How does the day-to-day look like for scientists that use Nanome ### View on Demand --- ![harris headshot](https://meet.nanome.ai/hubfs/harris%20headshot.jpg) ### Seth Harris, PhD Director of Computational Structural Biology & Distinguished Scientist at Genentech ## Exploring structural data landscapes for drug discovery: GYST, a Genentech platform with Nanome XR integration Recorded November 9th, 2022 Large-scale data extracts and annotations of structural features can accelerate drug discovery and research Genentech's platform GYST creates datasets and enables their exploration by a broad range of researchers, while also provisioning information for machine learning models Custom plugins enable seamless integration of Nanome as a visualization and analytical component in this system --- ![radic_headshot-3](https://meet.nanome.ai/hubfs/radic_headshot-3.png) ### Zoran Radić, PhD Adjunct Professor at UC San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ## Virtual Reality to Aid Antidote Design: Structure-based design to treat organophosphate poisoning Recorded June 22nd, 2022   Understanding spatial impaction of Novichok-inhibited acetylcholinesterase is greatly facilitated by VR 3D structures of Acetylcholinesterase help explain its catalysis and provide a template for structure-based design while revealing an unexpected paradox Structure-based analysis aided by VR accelerates the creation and refinement of antidotes against acetylcholinesterase poisoning --- ![brian atwood - centered](https://meet.nanome.ai/hubfs/brian%20atwood%20-%20centered.png) ### Brian Atwood, PhD Application Scientist at Iktos ![rohit_arora](https://meet.nanome.ai/hubfs/rohit_arora.jpg) ### Rohit Arora, PhD Application Scientist at Iktos ## AI for the Science Metaverse: how to accelerate drug discovery by using AI in VR Recorded May 26th, 2022   Iktos AI-technologies for generative chemistry and retrosynthesis planning   Makya web application: AI for de novo drug design Spaya web application: AI for discovering and prioritizing synthetic routes Using Iktos tools in Nanome: a perfect place to collaborate --- ![andrey](https://meet.nanome.ai/hubfs/andrey.jpg) ### Andrey Kovalevsky, PhD Senior R&D Scientist, Oak Ridge National Laboratory ## Designing from "inside" the COVID-19 viral protein: A novel chemical structure designed in VR Recorded January 26th, 2022 Novel chemical structures for inhibiting SARS-CoV-2 replication  VR-assisted structure-activity relationships   Why Oak Ridge National Laboratory combines neutrons and VR for structure-based drug design   How VR aids collaboration between structural biologists, medicinal chemists, and molecular modelers ### A recording of this webinar is not available --- ![Jackie von Salm is speaking at Nanome's next webinar](https://meet.nanome.ai/hubfs/JvS_HeadShot_1.jpeg) ### Jackie von Salm, PhD Cofounder and CSO at Psilera Bioscience ## Psychedelics & Virtual Reality: How VR aids GPCR drug discovery for a psychedelic biotech startup Recorded Wednesday, November 17th, 2021 Why psychedelic research is so promising & what's on the horizon Overcoming the challenges of communicating scientific research to investors Easy ways to improve spatial awareness of chemists and the impact that brings to the lab How Psilera is using Nanome to filter compounds ### View on Demand --- ![Wilian Cortopassi](https://meet.nanome.ai/hubfs/Wilian%20Cortopassi-1.jpg) ### Wilian Cortopassi Senior Expert in Data Science at Novartis Institutes for BioMedical Research (NIBR) ## The "Virtual" Reality of Drug Discovery at Novartis Recorded Thursday, October 21st, 2021   How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)   A case study of the main protease (Mpro) of SARS-CoV-2   Future outlook of VR at Novartis ### A recording of this webinar is not available. Click below to download our case study with Novartis instead. [Download Novartis Case Study](https://meet.nanome.ai/hubfs/Nanome%20Case%20Studies%20and%20Articles%202021/Novartis%20Case%20Study.pdf?hsLang=en) --- ![6abe93e5-a9d5-479a-8a9b-fb4c2da166ab_small](https://meet.nanome.ai/hubfs/6abe93e5-a9d5-479a-8a9b-fb4c2da166ab_small.jpeg) ### Woody Sherman Chief Computational Scientist at Roivant Discovery, former CSO at Silicon Therapeutics ## The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights. Recorded Tuesday, August 24th, 2021   What Roivant Discovery is doing with physics-driven drug design.  The importance of structure-based drug discovery.   Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design. ### View on Demand ![nanome_logo 5](https://meet.nanome.ai/hubfs/nanome_logo%205.svg "nanome_logo 5")   Nanome Inc hello@nanome.ai - Pricing - Blog - Press - Events - Demo Terms and Conditions © 2021 Copyright Nanome Inc. All Rights Reserved.   [Follow us on Twitter](https://twitter.com/nanome_inc) [Follow us on LinkedIn](https://www.linkedin.com/company/nanome-inc/) [Follow us on Facebook](https://www.youtube.com/nanome) [Follow us on Facebook](https://www.facebook.com/nanomeinc/) [Follow us on Instagram](https://www.instagram.com/nanome_inc/)